Yemen. The Supreme Board of Drugs and Medical Devices has withdrawn all formulations of the nitrofuran derivative, furazolidone, because many other safer and more effective alternatives are available.

Reference: Communications from the WHO Representative, Yemen, 17 December and 10 October 1998.